Optimizing diabetes management through glucose profiling: A case-based approach

Primary Care Diabetes

Volumn 2, Issue 4, 2008, Pages 167-173

  Streja, Dan A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glucose profiles; Postprandial hyperglycemia; Self monitoring of blood glucose

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; BLOOD; BLOOD GLUCOSE MONITORING; CARBOHYDRATE DIET; CASE REPORT; DIABETIC ANGIOPATHY; DIET RESTRICTION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; REVIEW; TREATMENT OUTCOME;

AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIETARY CARBOHYDRATES; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 56449129613     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2008.06.004     Document Type: Review

References (39)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 5 (2004) 1047-1053
2. Centers for Disease Control and Prevention, National diabetes fact sheet. United States, 2005, available from http://www.diabetes.org/diabetes-statistics.jsp (accessed October 6, 2005).
3. Klein R., Klein B.E., and Moss S.E. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann. Intern. Med. 124 1 Pt 2 (1996) 90-96
4. Stratton I.M., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
5. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569
6. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
7. Skyler J.S. Evidence for glycated hemoglobin targets from the diabetes control and complications trial. Endocr. Pract. 8 Suppl. 1 (2002) 27-30
8. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 29 Suppl. 1 (2006) S4-S42
9. L'Agence Nationale d'Accréditation et d'Evaluation en Santé. Follow-up of the type 2 diabetic patient excluding follow-up of complications. Recommendations of ANAES. Diabetes Metab. 25 Suppl. 2 (1999) 1-64
10. European Diabetes Policy Group 1999. A desktop guide to Type 2 diabetes mellitus. Diabet. Med. 16 9 (1999) 716-730
11. American Association of Clinical Endocrinologists, American College of Endocrinology. Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management-2002 update. Endocr. Pract. 8 Suppl. 1 (2002) 40-82
12. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Targets for glycemic control. Can. J. Diab. 27 Suppl. 2 (2003) S18-S20
13. 1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44 (1995) 968-983
14. Hempe J.M., Gomez R., McCarter Jr. R.J., and Chalew S.A. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J. Diabetes Complications 16 5 (2002) 313-320
15. 1c in the Diabetes Control and Complications Trial. Diabetes Care 25 (2002) 275-278
16. Hillman N., Herranz L., Grande C., Vaquero P.M., and Pallardo L.F. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?. Diabet. Med. 21 5 (2004) 468-470
17. Nichols J.H. What is accuracy and how close must the agreement be?. Diabetes Technol. Ther. 7 3 (2005) 558-562
18. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
19. Donnelly L.A., Morris A.D., Frier B.M., et al. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet. Med. 22 6 (2005) 749-755
20. Bouma M., Dekker J.H., de Sonnaville J.J., et al. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?. Diabetes Care 22 6 (1999) 904-907
21. Monnier L., Colette C., Rabasa-Lhoret R., et al. Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 25 4 (2002) 737-741
22. Avignon A., Radauceanu A., and Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20 12 (1997) 1822-1826
23. 1c. Diabetes Care 26 3 (2003) 881-885
24. Colette C., Ginet C., Boegner C., et al. Dichotomous responses of inter and postprandial hyperglycaemia to short-term calorie restriction in patients with type 2 diabetes. Eur. J. Clin. Invest. 35 4 (2005) 259-264
25. Rodriguez B.L., Lau N., Burchfiel C.M., et al. Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program. Diabetes Care 22 8 (1999) 1262-1265
26. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22 6 (1999) 920-924
27. Qiao Q., Pyorala K., Pyorala M., et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur. Heart J. 23 16 (2002) 1267-1275
28. de Vegt F., Dekker J.M., Ruhé H.G., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999) 926-931
29. Hanefeld M., et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39 12 (1996) 1577-1583
30. Sievers M.L., Bennett P.H., and Nelson R.G. Effect of glycemia on mortality in Pima Indians with type 2 diabetes. Diabetes 48 4 (1999) 896-902
31. Barrett-Connor E., and Ferrara A. Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo Study. Diabetes Care 21 8 (1998) 1236-1239
32. Pearson J., and Bergenstal R. Fine-tuning control: pattern management versus supplementation. View 1. Pattern management: an essential component of effective insulin management. Diabetes Spectrum 14 2 (2001) 75-78
33. Ohkubo Y., Kishikawa H., Araki E., et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28 (1995) 103-117
34. Welschen L.M.C., Bloemendal E., Nijpels G., et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28 6 (2005) 1510-1517
35. Langer O., Rodriguez D.A., Xenakis E.M.J., McFarland M.B., Berkus M.D., and Arrendondo F. Intensified versus conventional management of gestational diabetes. Am. J. Obstet. Gynecol. 170 4 (1994) 1036-1046
36. Jovanovic L. American Diabetes Association's Fourth International Workshop-Conference on Gestational Diabetes Mellitus: summary and discussion. Therapeutic interventions. Diabetes Care 21 Suppl. 2 (1998) B131-B137
37. American College of Obstetricians and Gynecologists, ACOG Practice Bulletin, Clinical management guidelines for obstetrician-gynecologists, Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994), Gestational diabetes, Obstet. Gynecol. 98 (3) (2001) 525-538.
38. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 27 Suppl. 1 (2004) S88-S90
39. McElduff A., Cheung N.W., McIntyre H.D., et al. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med. J. Aust. 183 7 (2005) 373-377